Cas No.: 535959-77-4
PRODUCT INFORMATION
Description
Cyclic(YCDGFYACYMDV) is a peptide that interacts with the HER2 signaling pathway. This peptide is reported to self-assemble into nanoparticles, which can transform into nanofibers upon binding to the HER2 receptor. This process can disrupt receptor dimerization and downstream signaling. It serves as a research tool for studying HER2-mediated pathways and apoptosis induction in vitro and in murine models.
Molecular Weight
1447.61
Purity
> 95%
Formula
C₆₅H₈₂N₁₂O₂₀S₃
Product Type
Targeting Peptide
Sequence
Tyr-Cys-Asp-Gly-Phe-Tyr-Ala-Cys-Tyr-Met-Asp-Val (Disulfide bridge: Cys2-Cys8)
Form (20 deg.C)
Solid
Storage Condition
Store the product under the recommended conditions in the Certificate of Analysis (CoA).
For Research Use Only | Not For Clinical Use
Related products
- C16Y Targeting Peptide (CAT#: OLY-1025-YS-7)
- F3 Targeting Peptide (CAT#: OLY-1025-YS-28)
- Cyclo(RADfK) Targeting Peptide (CAT#: OLY-1025-YS-61)
- Breast Cancer Targeting Peptide 18-4 (CAT#: OLY-1025-YS-23)
- REA Targeting Peptide (CAT#: OLY-1025-YS-66)
- CooP Targeting Peptide (CAT#: OLY-1025-YS-12)
- CREKA Targeting Peptide (CAT#: OLY-1025-YS-18)
- T9 Targeting Peptide (CAT#: OLY-1025-YS-19)
Online Inquiry
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.